Results 71 to 80 of about 4,498 (182)

Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057

Journal of Infection and Public Health
Background: Polymedication and comorbidities are frequent in aging people with HIV (PWH) and often associated with elevated incidences of adverse events (AEs) and drug-drug interactions (DDIs).
Minh P. Lê, Clotilde Allavena, Véronique Joly, Lambert Assoumou, Valentina Isernia, Faiza Ajana, Didier Neau, Diane Descamps, Charlotte Charpentier, Aïda Benalycherif, Bao Phung, Gilles Peytavin, Roland Landman   +12 more
doaj   +1 more source

Darunavir/Cobicistat [PDF]

, 2020
openaire   +1 more source

Atazanavir/Cobicistat [PDF]

, 2020
openaire   +1 more source

Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat. [PDF]

Br J Clin Pharmacol
van Ton AMP, van Erp NP, van de Ven AC, Walraven JEW, de Jong LAW.   +4 more
europepmc   +1 more source

Addressing model overcomplexity in drug-drug interaction prediction with molecular fingerprints. [PDF]

J Cheminform
Gil-Sorribes M, Molina A.
europepmc   +1 more source

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Gurney J, Gandhi-Patel B, Unger N, Mordi U, Chen M, Jarrett J, Sherman EM, Mounzer K, Khalsa AM, Dinges WL, McKellar MS, Lipps A.   +17 more
europepmc   +1 more source

Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China. [PDF]

Prev Med Rep
Cheng W, Zhang Y, Yang J, Jiang J, Pan X, Chai C, Wang Y.   +6 more
europepmc   +1 more source

Validation of a LC-MS/MS Assay for Rapid and Simultaneous Quantification of Cobicistat and Venetoclax in Human Plasma and Serum. [PDF]

Biomed Chromatogr
Westra N, van Hateren K, Kosterink JGW, Lub-de Hooge MN, Oude Munnink TH, Touw DJ.   +5 more
europepmc   +1 more source

Osimertinib Cost Minimization in Non-Small Cell Lung Cancer (NSCLC) Treatment: Hypothesis Generation for a Population Pharmacokinetic Approach for Equivalent Dose Optimization of Osimertinib in Combination with Cobicistat. [PDF]

J Clin Pharmacol
Westra N, Kruithof PD, Croes S, van Geel RMJM, Hendriks LEL, Touw DJ, Kosterink JGW, Stevens J, Oude Munnink TH, Mian P.   +9 more
europepmc   +1 more source

Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. [PDF]

Front Pharmacol
Spanakis M, Alexakis K, Ioannou P.
europepmc   +1 more source